Skip to main content
. 2021 Mar 23;50(6):1914–1926. doi: 10.1093/ije/dyab032

Table 5a.

Cross-classification by weight change, body mass index at age 20 years (BMI20) and hormone replacement therapy (HRT) with the same BMI and HRT status as reference

Postmenopausal (n = 66 479/ca = 3409)b
Never HRT users (n = 33 531)
Ever HRT users (n = 32 948)
BMI20 <25 kg/m2 ca = 939
BMI20 ≥25 kg/m2 ca = 430
BMI20 <25 kg/m2 ca = 1 412
BMI20 ≥25 kg/m2 ca = 628
Weight change (kg) Cases (n) HRa 95% CI Cases (n) HR 95% CI Cases (n) HR 95% CI Cases (n) HR 95% CI
<–2.5 28 0.91 0.64 1.30 60 0.88 0.60 1.28 50 0.94 0.68 1.29 64 1.07 0.67 1.73
±2.5 81 1.00 Ref. 53 1.00 Ref. 111 1.00 Ref. 76 1.00 Ref.
2.51–5 60 1.14 0.88 1.47 44 0.92 0.64 1.32 119 1.16 0.92 1.46 73 1.39 0.91 2.11
5.1–10 183 1.23 0.98 1.54 73 0.81 0.59 1.10 347 1.23 1.01 1.51 134 1.30 0.90 1.86
10+ 587 1.52 1.24 1.86 200 1.05 0.80 1.37 785 1.31 1.08 1.58 281 1.33 0.95 1.87
a

Stratified by centre and age at recruitment (categorical 5-year interval) and adjusted for weight at age 20 years, height, age at menarche, age at first pregnancy, education, alcohol consumption, smoking status, physical activity and use of oral contraceptives.

b

Out of 71 751 postmenopausal women at cohort entry, 66 479 women had informaton on BMI at age 20 years and HRT. Out of 4891 postmenopausal breast-cancer cases, 3409 breast-cancer cases had information on BMI at age 20 years and HRT.

95% CI, 95% confidence interval; HR, hazard ratio.